Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Can Cannabis CBD Alone Reduce Apnoea-Hypopnea Index (AHI)? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Cannabis CBD has gained attention as a potential adjunct therapy for obstructive sleep apnoea (OSA) . Researchers are examining whether CBD for apnoea-hypopnea index can help lower the number of respiratory events during sleep. Early evidence suggests cannabidiol may influence sleep architecture and respiratory stability, though clinical data remain limited. 

Am I eligible for medical cannabis for pain relief?

Potential Impact of CBD on AHI 

Exploring CBD for apnoea-hypopnea index may inform future OSA treatment strategies. 

Respiratory Regulation 

Cannabidiol for AHI reduction may support smoother breathing patterns by modulating neurochemical pathways involved in respiratory control. 

Sleep Quality Improvement 

CBD has been observed to improve sleep continuity, which could indirectly contribute to CBD for OSA outcomes by reducing sleep fragmentation associated with apnoea events. 

Anti-Inflammatory Effects 

Cannabidiol’s anti-inflammatory properties may lessen airway inflammation, potentially aiding cannabidiol for AHI reduction in patients with upper airway obstruction. 

Safety Profile 

CBD is generally well tolerated, making CBD for apnoea-hypopnea index an attractive option for those seeking non-psychoactive alternatives to THC or pharmacologic therapies. 

Clinical Evidence 

Current studies are limited, and CBD for OSA outcomes require more rigorous trials to confirm efficacy, optimal dosing, and long-term safety. 

While preliminary data suggest CBD for apnoea-hypopnea index could provide benefits, further research is needed before CBD can be recommended as a standalone treatment for OSA. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea .

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories